Long-acting diltiazem CD is safe and effective in a hypertensive Mexican-American population

Pharmacotherapy

Volumn 17, Issue 6, 1997, Pages 1254-1259

  Herrera, Carlos R ^a   Lewin, Andrew ^b   Fiddes, Robert ^c   Friedman, Jon ^d   Linn, William ^e   Baker, Thomas ^f   Balanoff, Diane ^f   Beach, C L ^f  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL RESEARCH INSTITUTE   (United States)

^c S California Research Institute   (United States)

^d Healthcare Partners Medical Group   (United States)

^e SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^f Hoechst Marion Roussel   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; LONG ACTING DRUG; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; HEADACHE; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DILTIAZEM; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MEXICAN AMERICANS; MIDDLE AGED;

EID: 0030686574     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Joint National Commission on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-83.
2. Caralis PV. Coronary artery disease in Hispanic Americans. How does ethnic background affect risk factors and mortality rates? Postgrad Med 1992;91:179-93.
3. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six hypertensive agents with placebo. N Engl J Med 1993;328:914-21.
4. National Coalition of Health and Human Services Organizations (COSSMHO). Meeting the health promotion needs of Hispanic communities. Am J Health Promot 1995;9:300-11.
5. Caralis PV. Hypertension in the Hispanic population. Am J Med 1990;88(suppl):9S-16.
6. Haffner SM, Morales PA, Hazuda HP, Stern MP. Level of control of hypertension in Mexican-Americans and non-Hispanic whites. Hypertension 1993;21:83-8.
7. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M. A comparison of three indicators for identifying Mexican-Americans in epidemiological research. Am J Epidemiol 1986;123:96-112.
8. Vega WA, Amaro H. Latino outlook: good health, uncertain prognosis. Annu Rev Public Health 1994;15:39-67.
9. Sorel JE, Ragland DR, Syme SL. Blood pressure in Mexican-Americans, whites and blacks. The 2nd national health and nutritional examination survey and the Hispanic health and nutritional examination survey. Am J Epidemiol 1991;134: 370-8.
10. Haffner SM, Mitchell BD, Valdez RA, et al. Eight year incidence of hypertension in Mexican-Americans and non-Hispanic whites-the San Antonio heart study. Am J Hypertens 1992;5:147-53.
11. Massie BM, Der E, Herman TS, et al. 24-Hour efficacy of once-daily diltiazem in essential hypertension. Clin Cardiol 1992;15:365-8.
12. Felicetta JV, Serfer HM, Cutler NR, et al. A dose-response trial of once-daily diltiazem. Am Heart J 1992;123:1022-6.
13. Cangiano JL. Hypertension in Hispanic Americans. Cleve Clin J Med 1994;61:345-50.